Lord SR - Search Results

1

Obesity: a perfect storm for carcinogenesis.

Harris BHL, Macaulay VM, Harris DA, Klenerman P, Karpe F, Lord SR, Harris AL, Buffa FM. Harris BHL, et al. Among authors: lord sr. Cancer Metastasis Rev. 2022 Sep;41(3):491-515. doi: 10.1007/s10555-022-10046-2. Epub 2022 Aug 30. Cancer Metastasis Rev. 2022. PMID: 36038791 Free PMC article. Review.

2

Angiogenesis - still a worthwhile target for breast cancer therapy?

Lord S, Harris AL. Lord S, et al. Breast Cancer Res. 2010 Dec 20;12 Suppl 4(Suppl 4):S19. doi: 10.1186/bcr2748. Breast Cancer Res. 2010. PMID: 21172081 Free PMC article. No abstract available.

3

Gene expression and hypoxia in breast cancer.

Favaro E, Lord S, Harris AL, Buffa FM. Favaro E, et al. Genome Med. 2011 Aug 26;3(8):55. doi: 10.1186/gm271. Genome Med. 2011. PMID: 21875443 Free PMC article.

4

Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation.

Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, Pinnick KE, Wigfield S, Buffa FM, Li JL, Zhang Q, Wakelam MJO, Karpe F, Schulze A, Harris AL. Bensaad K, et al. Cell Rep. 2014 Oct 9;9(1):349-365. doi: 10.1016/j.celrep.2014.08.056. Epub 2014 Sep 25. Cell Rep. 2014. PMID: 25263561 Free article.

5

Imaging tumour hypoxia with positron emission tomography.

Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, Domarkas J, Lord S, Baldry C, Gilbert FJ. Fleming IN, et al. Br J Cancer. 2015 Jan 20;112(2):238-50. doi: 10.1038/bjc.2014.610. Epub 2014 Dec 16. Br J Cancer. 2015. PMID: 25514380 Free PMC article. Review.

6

Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.

Lord SR, Patel N, Liu D, Fenwick J, Gleeson F, Buffa F, Harris AL. Lord SR, et al. J Natl Cancer Inst Monogr. 2015 May;2015(51):81-6. doi: 10.1093/jncimonographs/lgv011. J Natl Cancer Inst Monogr. 2015. PMID: 26063894 Review.

7

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality.

Lord S, Funes JM, Harris AL, Quintela-Fandino M. Lord S, et al. Curr Drug Targets. 2016;17(15):1714-1727. doi: 10.2174/1389450117666160307143718. Curr Drug Targets. 2016. PMID: 26953245 Review.

8

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.

Mehta S, Hughes NP, Li S, Jubb A, Adams R, Lord S, Koumakis L, van Stiphout R, Padhani A, Makris A, Buffa FM, Harris AL. Mehta S, et al. EBioMedicine. 2016 Aug;10:109-16. doi: 10.1016/j.ebiom.2016.07.017. Epub 2016 Jul 16. EBioMedicine. 2016. PMID: 27474395 Free PMC article.

9

Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.

Morotti M, Dass PH, Harris AL, Lord S. Morotti M, et al. Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):137-153. doi: 10.1007/s13318-017-0442-x. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29019020 Review.

10

Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.

Lord SR, Cheng WC, Liu D, Gaude E, Haider S, Metcalf T, Patel N, Teoh EJ, Gleeson F, Bradley K, Wigfield S, Zois C, McGowan DR, Ah-See ML, Thompson AM, Sharma A, Bidaut L, Pollak M, Roy PG, Karpe F, James T, English R, Adams RF, Campo L, Ayers L, Snell C, Roxanis I, Frezza C, Fenwick JD, Buffa FM, Harris AL. Lord SR, et al. Cell Metab. 2018 Nov 6;28(5):679-688.e4. doi: 10.1016/j.cmet.2018.08.021. Epub 2018 Sep 20. Cell Metab. 2018. PMID: 30244975 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

555 results

Search Page